首站-论文投稿智能助手
典型文献
Technical aspects in pancreaticoduodenectomy and therapeutic strategies for pancreatic cancer:History,current status,and future perspectives
文献摘要:
The incidence of pancreatic cancer(PC)has increased,and in-vasive ductal adenocarcinoma is the most common among PC pa-tients[1].Even in patients who receive radical treatments,namely chemotherapy and surgery,the five-year survival is only 2%-9%[1].Currently,many physicians recognize that further developments in multidisciplinary therapy are crucial to overcome PC[1]. Pancreaticoduodenectomy is the primary therapy for malignan-cies in duodenal ampulla of Vater,extrahepatic biliary duct,pan-creatic head and the uncinate process.In particular,this surgery plays an important role in multidisciplinary therapy for PC,al-though intractable complications and refractory symptoms may oc-cur postoperatively,and a postoperative mortality of<10%has been documented[2].In this paper,we present the history,current status,and future perspectives of the technical aspects of pancre-aticoduodenectomy and the therapeutic strategies for PC.
文献关键词:
作者姓名:
Tomohide Hori;Daiki Yasukawa
作者机构:
Department of Surgery,Shiga General Hospital,Moriyama 524-8524,Japan;Department of Surgery,Shiga University of Medical Science,Otsu 520-2192,Japan
引用格式:
[1]Tomohide Hori;Daiki Yasukawa-.Technical aspects in pancreaticoduodenectomy and therapeutic strategies for pancreatic cancer:History,current status,and future perspectives)[J].国际肝胆胰疾病杂志(英文版),2022(06):600-602
A类:
Pancreaticoduodenectomy,malignan,uncinate,aticoduodenectomy
B类:
Technical,aspects,pancreaticoduodenectomy,therapeutic,strategies,cancer,History,current,status,future,perspectives,incidence,has,increased,vasive,ductal,adenocarcinoma,most,common,among,Even,patients,who,receive,radical,treatments,namely,chemotherapy,surgery,five,year,survival,only,Currently,many,physicians,recognize,that,further,developments,multidisciplinary,are,crucial,overcome,primary,cies,duodenal,ampulla,Vater,extrahepatic,biliary,head,process,In,particular,this,plays,important,role,though,intractable,complications,refractory,symptoms,may,postoperatively,mortality,been,documented,paper,we,present,history,technical
AB值:
0.57176
相似文献
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
Yu Yu;Minzhen Tao;Libin Xu;Lei Cao;Baoyu Le;Na An;Jilin Dong;Yajie Xu;Baoxing Yang;Wei Li;Bing Liu;Qiong Wu;Yinying Lu;Zhen Xie;Xiaohua Lian-Department of Cell Biology,Basic Medical College,Army Medical University(Third Military Medical University),Chongqing 400038,China;MOE Key Laboratory of Bioinformatics and Bioinformatics Division,Center for Synthetic and System Biology,Department of Automation,Beijing National Research Center for Information Science and Technology,Tsinghua University,Beijing 100084,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Thoracic Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China;Beijing Syngentech Co.,Ltd,Beijing 102206,China;School of Life Sciences,Tsinghua University,Beijing 100084,China;The Comprehensive Liver Cancer Center,The 5th Medical Center of PLA General Hospital,Beijing 100039,China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。